Pharmacognosy and Effects of Cannabinoids in the Vascular System

Abstract

Understanding the pharmacodynamics of cannabinoids is an essential subject due to the recent increasing global acceptance of cannabis and its derivation for recreational and therapeutic purposes. Elucidating the interaction between cannabinoids and the vascular system is critical to exploring cannabinoids as a prospective therapeutic agent for treating vascular-associated clinical conditions. This review aims to examine the effect of cannabinoids on the vascular system and further discuss the fundamental pharmacological properties and mechanisms of action of cannabinoids in the vascular system. Data from literature revealed a substantial interaction between endocannabinoids, phytocannabinoids, and synthetic cannabinoids within the vasculature of both humans and animal models. However, the mechanisms and the ensuing functional response is blood vessels and species-dependent. The current understanding of classical cannabinoid receptor subtypes and the recently discovered atypical cannabinoid receptors and the development of new synthetic analogs have further enhanced the pharmacological characterization of the vascular cannabinoid receptors. Compelling evidence also suggest that cannabinoids represent a formidable therapeutic candidate for vascular-associated conditions. Nonetheless, explanations of the mechanisms underlining these processes are complex and paradoxical based on the heterogeneity of receptors and signaling pathways. Further insight from studies that uncover the mechanisms underlining the therapeutic effect of cannabinoids in the treatment of vascular-associated conditions is required to determine whether the known benefits of cannabinoids thus currently outweigh the known/unknown risks.

The Impact of Marijuana Use on Postoperative Outcomes in Abdominal-based Free Flap Breast Reconstruction

“…It is worth noting that marijuana also inhibits platelet function and has been suggested to increase the risk of bleeding. 33 Balancing these competing mechanisms and providing a comprehensive understanding of the postoperative complication risk profile associated with marijuana use is challenging given the limited clinical data available currently.…”

Research progress in the management of vascular disease with cannabidiol: a review

“…Dysregulation of vascular wall tension plays an important role in the pathogenesis of hypertension [ 56 ]. CBD regulates vascular wall tension via the following mechanisms: (1) In vitro, CBD directly activates CB1, G protein-coupled receptor 55 (GPR55), TRPV1, PPARs, and 5-HT1A in the vessels, causing vasodilation [ 57 , 58 ]; (2) CBD activates GPR18 receptors in peripheral blood vessels and the ventrolateral central medulla oblongata, leading to vasodilation and hypotension [ 59 , 60 ]; (3) CBD enhances COX activity, which increases the production of vasodilatory mediators (such as prostaglandins and nitric oxide) [ 61 , 62 ]; (4) CBD regulates the function of potassium and calcium channels, thereby regulating vascular wall tension [ 62 , 63 ].…”

Comparative Study of Gas and Liquid Chromatography Methods for the Determination of Underivatised Neutral and Acidic Cannabinoids and Cholesterol

“…Fortunately, both diet composition and dietary supplements (e.g., non-psychotropic CBDs and plant or fish oils rich in n-3PUFA) can increase the nutritional value of plant and animal products, thereby benefiting human health [6][7][8][9][10]. Moreover, non-psychotropic CBDs have also shown efficacy in preventing vascular diseases in humans [11]. Interestingly, nonpsychotropic CBDs have been found to reduce fungal growth (both in vitro and in vivo), and alter the composition of fungal cell walls and membrane integrity [6].…”